NEUMÜNSTER, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) — Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare today announced the expansion of its Tilray Craft portfolio in Germany with five new cannabis flower products produced in Germany at Tilray’s EU‑GMP certified facility in Neumünster as part of the BfArM in‑country cultivation program. The additions reflect Tilray’s ongoing commitment to providing physicians and pharmacies with a diverse range of quality, EU‑GMP certified medical cannabis options for eligible patients.
Rajnish Ohri, Managing Director International at Tilray Brands, commented, “The expansion of our Tilray Craft premium cannabis flower range demonstrates our commitment to…
